Revvity (RVTY) Share-based Compensation (2009 - 2026)
Revvity's (RVTY) quarterly Share-based Compensation came in at $8.7 million in Q2 2026, up 12.73% YoY from $7.7 million in Q2 2025, and up 314.08% on a QoQ basis from -$4.1 million in Q4 2025.
Revvity (RVTY) Share-based Compensation (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Share-based Compensation data on file, last reported at $8.7 million in Q2 2026.
- Quarterly Share-based Compensation rose 12.73% year-over-year to $8.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $23.8 million (down 29.59% YoY) and the FY2025 annual result came in at $22.8 million, down 39.57% from the prior year.
- Share-based Compensation improved to $8.7 million in Q2 2026, from -$4.1 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $34.8 million in Q1 2023 to a low of -$4.1 million in Q4 2025.
- A 5-year average of $10.7 million and a median of $10.1 million in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 179.97% — and 2025, when it sank 180.57%.
- Tracing RVTY's Share-based Compensation over 5 years: stood at $14.4 million in 2022, then slumped by 50.26% to $7.2 million in 2023, then fell by 29.63% to $5.1 million in 2024, then slumped by 180.57% to -$4.1 million in 2025, then soared by 314.08% to $8.7 million in 2026.
- The last three Share-based Compensation figures came in at $8.7 million (Q2 2026), -$4.1 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 103.10 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 95.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 16.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 73.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 4.96 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 26.80 Mn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 10.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 10.73 Mn |
| Jul 5, 2026 | 10.73 Mn |
| Apr 5, 2026 | 8.72 Mn |
| Apr 5, 2026 | 8.72 Mn |
| Dec 28, 2025 | -4.07 Mn |
| Dec 28, 2025 | -4.07 Mn |
| Sep 28, 2025 | 9.05 Mn |
| Sep 28, 2025 | 9.05 Mn |
| Jun 29, 2025 | 10.13 Mn |
| Jun 29, 2025 | 10.13 Mn |
| Mar 30, 2025 | 7.73 Mn |
| Mar 30, 2025 | 7.73 Mn |
| Dec 29, 2024 | 5.05 Mn |
| Dec 29, 2024 | 5.05 Mn |
| Sep 29, 2024 | 10.54 Mn |
| Sep 29, 2024 | 10.54 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Mar 31, 2024 | 11.69 Mn |